- Report
- August 2024
- 178 Pages
Global
From €2214EUR$2,500USD£1,916GBP
- Report
- July 2024
- 139 Pages
Global
From €2214EUR$2,500USD£1,916GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2214EUR$2,500USD£1,916GBP
- Report
- August 2024
- 268 Pages
Global
From €3189EUR$3,600USD£2,759GBP
- Report
- August 2024
- 110 Pages
North America
From €1329EUR$1,500USD£1,150GBP
- Report
- August 2024
- 121 Pages
Africa, Middle East
From €1329EUR$1,500USD£1,150GBP
- Report
- August 2024
- 121 Pages
Europe
From €1329EUR$1,500USD£1,150GBP
- Report
- August 2024
- 121 Pages
Asia Pacific
From €1329EUR$1,500USD£1,150GBP
- Report
- February 2022
- 195 Pages
Global
From €3189EUR$3,600USD£2,759GBP
- Report
- May 2024
- 145 Pages
Global
From €2799EUR$3,160USD£2,422GBP
€3499EUR$3,950USD£3,027GBP
- Report
- April 2024
- 100 Pages
Africa
From €886EUR$1,000USD£766GBP
€1772EUR$2,000USD£1,533GBP
- Report
- April 2024
- 80 Pages
India
From €664EUR$750USD£575GBP
€1329EUR$1,500USD£1,150GBP
- Report
- April 2024
- 80 Pages
United States
From €664EUR$750USD£575GBP
€1329EUR$1,500USD£1,150GBP
- Report
- July 2025
- 200 Pages
India
From €2470EUR$2,789USD£2,137GBP
- Report
- June 2025
- 250 Pages
Canada
From €2470EUR$2,789USD£2,137GBP
- Report
- August 2024
- 150 Pages
Global
From €2470EUR$2,789USD£2,137GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3427EUR$3,869USD£2,965GBP
- Report
- May 2023
- 160 Pages
Global
From €4384EUR$4,949USD£3,793GBP
- Report
- May 2023
- 147 Pages
Global
From €4384EUR$4,949USD£3,793GBP
- Report
- March 2023
- 147 Pages
Global
From €4384EUR$4,949USD£3,793GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more